Retracted: Apoptosis and Molecular Targeting Therapy in Cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Sonogenetics in the Treatment of Chronic Diseases: A New Method for Cell Regulation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
   Review
2. scRNA sequencing technology for PitNET studies.Frontiers in endocrinology · 2024
   Review
3. Unraveling cancer progression pathways and phytochemical therapeutic strategies for its management.Frontiers in pharmacology · 2024
   Review
4. Virtual Screening-Based Study of Novel Anti-Cancer Drugs Targeting G-Quadruplex.Pharmaceutics · 2023
   Article
5. The Lack of Standardization and Pharmacological Effect Limits the Potential Clinical Usefulness of Phytosterols in Benign Prostatic Hyperplasia.Plants (Basel, Switzerland) · 2023
   Review
6. Study on the molecular mechanism of nightshade in the treatment of colon cancer.Bioengineered · 2022
   Article

Corrections and comments

• Retraction of
  Apoptosis and molecular targeting therapy in cancer.2014

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract